NEW YORK (GenomeWeb) – Germany's Merck KGaA reported today that its revenues for fiscal year 2015 climbed 13 percent year over year, driven by growth in its life science segment and including the contribution of Sigma-Aldrich.
Sales for the life science segment jumped 25 percent year over year to €3.36 billion ($3.71 billion) from €2.68 billion. Within that segment, the company's process solutions business had sales of €1.43 billion, while sales for its lab solutions business were around €1.20 billion, and revenues for the bioscience business area were €450 million.